Form 8-K Akebia Therapeutics, For: Aug 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Akebia Therapeutics (AKBA) Posts Q2 Loss of 40c/Share
August 11, 2015 4:33 PM EDTAkebia Therapeutics (NASDAQ: AKBA) reported Q2 EPS of ($0.40), $0.11 better than the analyst estimate of ($0.51).
For earnings history and earnings-related data on Akebia Therapeutics (AKBA) click here.
... MoreAkebia Therapeutics (AKBA) Discloses $50M ATM Offering
August 11, 2015 4:28 PM EDTAkebia Therapeutics (NASDAQ: AKBA) filed a prospectus supplement with the Securities and Exchange Commission that contemplates the sale of up to $50 million of shares of the Companys common stock, $0.00001 par value per share, from time to time in at-the-market offerings pursuant to a... More
